How many boxes of pemetinib/pemetinib should be taken per month?
Pemigatinib/Pemigatinib is a kinase inhibitor that blocks the action of protein kinases. Pemetinib is a prescription drug used in adults to treat cholangiocarcinoma that has spread to other parts of the body (metastatic) or cannot be removed with surgery. This drug is usually given after the cancer has been treated with another drug and when the cancer has a certain type of abnormal FGFR2 gene. Pemetinib is also used in adults to treat a type of blood cancer called myeloid/lymphoid neoplasms (MLNs) when the cancer comes back or doesn't respond to treatment, and when the cancer has a certain type of abnormal FGFR1 gene.
The U.S. Food and Drug Administration (FDA) approved pemetinib on an “accelerated” basis for the treatment of cholangiocarcinoma. In clinical studies, some people responded to pemmasire, but further research is needed. In the treatment plan of pemetinib, the recommended daily oral dose is 13.5 mg, which is taken continuously for 14 days and then stopped for 7 days, so that 21 days constitute a complete treatment cycle. Treatment will continue until the condition worsens or the patient develops intolerable drug toxicity.

Common pemetinib dosage specifications on the market include4.5 mg 14 tablets, 9 mg 14 tablets and 13.5 mg 14 tablets. If calculated based on the specification of 13.5 mg and 14 tablets, theoretically, patients need to take approximately 2 boxes of medicine within a month. However, this amount is not fixed. If a patient experiences adverse reactions after taking pemetinib, the doctor may adjust the drug dosage based on the patient's specific condition to ensure the safety and effectiveness of the treatment.
Therefore, the specific monthly dosage of pemetinib should be comprehensively determined based on the patient’s actual condition, doctor’s recommendations and drug specifications. During the treatment process, patients should pay close attention to their physical condition and communicate with the doctor in a timely manner to ensure the best treatment effect.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)